Contract R&D SynChem is a small to mid-sized chemistry-focused CRO with extensive experience in organic synthesis, process development and medicinal chemistry, offering a solid track record of 4,500+ projects and multiple patents, making them a potential partner for pharma and biotech firms seeking outsourced development and scalable synthesis.

Industry Focus With a client base spanning multi-national pharmaceutical companies, biotech firms, drug discovery companies, and chemical/agrochemical sectors, SynChem presents opportunities across early discovery through scale-up, especially for partners needing specialized chemistry expertise and flexible engagement models.

Global Access Located near Chicago and serving diverse customers, SynChem’s geographic footprint and regional presence can facilitate collaborations for North American drug development programs, with potential for on-site or hybrid models to streamline communication and project management.

Innovation Edge The company’s patent activity and published scientific work signal ongoing R&D emphasis; sales outreach can emphasize access to proprietary methodologies, optimization capabilities, and differentiating chemistry solutions for difficult synthesis challenges.

Growth Signals With reported revenue in the mid-range for a CRO of its size and a notable project-to-market success rate, there is potential to expand through longer-term retainer models, expanded service bundles (from discovery to process development), and strategic partnerships for pipeline advancement.